A separate study conducted in 114 older adults with unimpaired cognition, mild cognitive impairment, or AD reported that plasma GFAP levels explained 25% of the variance in memory, as well 10%–15% of the variance in visuospatial, language/semantic knowledge, and executive function domains.20 The gene discussed is GFAP; the disease is Alzheimer disease.